M&T Bank
AMRX icon

M&T Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

M&T Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Buy
23,862
+606
+3% +$8.3K ﹤0.01% 1298
2026
Q1 		$289K Sell
23,256
-271
-1% -$3.64K ﹤0.01% 1398
2025
Q4 		$296K Buy
+23,527
New +$269K ﹤0.01% 1407

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

M&T Bank's AMRX Position: Q2 2026 in Review

M&T Bank increased its Amneal Pharmaceuticals (AMRX) stake by 2.6% in Q2 2026, buying an estimated $8.3K and bringing the position to 23,862 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

M&T Bank first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • M&T Bank held 23,862 shares of Amneal Pharmaceuticals worth $413K as of Q2 2026.
  • M&T Bank bought 606 Amneal Pharmaceuticals shares in Q2 2026, an estimated $8.3K.
  • Amneal Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1298 holding.
  • M&T Bank first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.